CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients

doi:10.4254/wjh.v9.i25.1073

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8857)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

390

WORD

182

HTML

3111

Figures (1-3)

317

Tables (1-2)

306

Sum=4306

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

551

Download

1153

Sum=1704

Publishing Process of This Article

Item

Count

Browse

1040

Download

1807

Sum=2847

Sep 8, 2017 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Sep 8, 2017; 9(25): 1073-1080
Published online Sep 8, 2017. doi: 10.4254/wjh.v9.i25.1073

Table 1 Fluorochrome-conjugated antibodies panels

Antibody	Fluorochrome	Clone	Provider
All panels
Anti-CD3	APC/Cy7	SK7	BioLegend
Anti-CD56	PE/Cy5	679.1Mc7	Beckman Coulter
Panel 1
Anti-CD57	APC	HNK-1	BioLegend
Anti-CD25	PE	BC96	BioLegend
Anti-CD69	FITC	FN50	BioLegend
Panel 2
Anti-NKp30	PE	P30-15	Biolegend
Anti-NKp46	PE/Cy7	9E2	Biolegend
Anti-NKG2D	APC	1D11	Biolegend
Anti-DNAM	FITC	TX25	Biolegend
Panel 3
Anti-CD62L	PE/Cy7	DREG-56	Biolegend
Anti-CCR7	PE	G043H7	Biolegend
Panel 4
Anti-TRAIL	PE	S35-934	BD Bioscience
Panel 5
Anti-FasL	PE	NOK-1	Biolegend
Anti CD94	FITC	DX22	Biolegend

BioLegend, San Diego, California United States. BD Bioscience, San Jose, California, United States. NK: Natural killer.

Citation: Laufer N, Ojeda D, Polo ML, Martinez A, Pérez H, Turk G, Cahn P, Zwirner NW, Quarleri J. CD4⁺ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients. World J Hepatol 2017; 9(25): 1073-1080
URL: https://www.wjgnet.com/1948-5182/full/v9/i25/1073.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i25.1073